IS2906B - Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli - Google Patents

Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli

Info

Publication number
IS2906B
IS2906B IS7320A IS7320A IS2906B IS 2906 B IS2906 B IS 2906B IS 7320 A IS7320 A IS 7320A IS 7320 A IS7320 A IS 7320A IS 2906 B IS2906 B IS 2906B
Authority
IS
Iceland
Prior art keywords
hpv
peptide
treatment
hepatocellular carcinoma
human hepatocellular
Prior art date
Application number
IS7320A
Other languages
English (en)
Other versions
IS7320A (is
Inventor
Silvio Ernesto Perea Rodriguez
Osvaldo Reyes Acosta
Nelson Francisco Santiago Vispo
Yaquelín Puchades Izaguirre
Ricardo Silva Rodriguez
Alejandro Moro Soria
Alicia Santos Savio
Luis Javier Gonzalez Lopez
Belkis Gonzalez Barrios
Original Assignee
Ct De Ingeniería Genética Y Biotecnología
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Ingeniería Genética Y Biotecnología filed Critical Ct De Ingeniería Genética Y Biotecnología
Publication of IS7320A publication Critical patent/IS7320A/is
Publication of IS2906B publication Critical patent/IS2906B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS7320A 2001-12-20 2004-06-16 Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli IS2906B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20010309A CU23225A1 (es) 2001-12-20 2001-12-20 PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
PCT/CU2002/000010 WO2003054002A1 (es) 2001-12-20 2002-12-04 Péptidos para el tratamiento del cáncer asociado al virus papiloma humano (vph) y de otros tumores epiteliales

Publications (2)

Publication Number Publication Date
IS7320A IS7320A (is) 2004-06-16
IS2906B true IS2906B (is) 2014-11-15

Family

ID=40091679

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7320A IS2906B (is) 2001-12-20 2004-06-16 Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli

Country Status (34)

Country Link
US (2) US7374767B2 (is)
EP (2) EP1491553B1 (is)
JP (1) JP4056476B2 (is)
KR (1) KR100642437B1 (is)
CN (1) CN100368431C (is)
AR (1) AR037825A1 (is)
AT (1) ATE520704T1 (is)
AU (1) AU2002361922B2 (is)
BR (1) BRPI0215213C1 (is)
CA (1) CA2471110C (is)
CR (1) CR7361A (is)
CU (1) CU23225A1 (is)
DK (1) DK1491553T3 (is)
DO (1) DOP2002000548A (is)
ES (1) ES2371239T3 (is)
HK (1) HK1068901A1 (is)
HN (1) HN2002000377A (is)
HR (1) HRP20040663B1 (is)
IL (2) IL162633A0 (is)
IS (1) IS2906B (is)
MA (1) MA27868A1 (is)
MX (1) MXPA04005832A (is)
MY (1) MY133530A (is)
NO (1) NO333259B1 (is)
NZ (1) NZ534170A (is)
PE (1) PE20030861A1 (is)
PT (1) PT1491553E (is)
RU (1) RU2290410C2 (is)
SI (1) SI1491553T1 (is)
TN (1) TNSN04114A1 (is)
UA (1) UA81403C2 (is)
UY (1) UY27602A1 (is)
WO (1) WO2003054002A1 (is)
ZA (1) ZA200405514B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) 2005-05-12 2009-10-16 Ct Ingenieria Genetica Biotech Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en) * 2005-12-23 2007-07-04 Rapid Biosensor Systems Ltd Detection of tuberculosis infection
CU23511B6 (es) * 2006-02-28 2010-04-13 Biorec B V Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
CN100522992C (zh) * 2007-02-12 2009-08-05 中国科学院昆明动物研究所 一种环状小肽ba
CN101641104B (zh) * 2007-03-27 2013-06-05 大幸药品株式会社 感染性皮肤和粘膜疾病治疗药
US20110305706A1 (en) 2009-02-23 2011-12-15 Scott Thomas Brady Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
WO2010105277A1 (en) * 2009-03-13 2010-09-16 Egen, Inc. Compositions and methods for the delivery of biologically active rnas
RU2744860C2 (ru) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Антитела и их конъюгаты
CU20200103A7 (es) * 2020-12-18 2022-07-08 Ct Ingenieria Genetica Biotecnologia Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU20210058A7 (es) 2021-07-09 2023-02-13 Ct Ingenieria Genetica Biotecnologia Péptidos lineales que inhiben la fosforilación mediada por ck2 y composiciones que los comprenden

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902820A1 (en) * 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
JPH05310784A (ja) * 1991-09-04 1993-11-22 Merck & Co Inc ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
GB9313556D0 (en) * 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
DE69812597D1 (de) 1998-06-30 2003-04-30 Deutsches Krebsforsch Peptide zur Inhibition von HPV E7 Proteinen
US6641994B2 (en) 1999-08-25 2003-11-04 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Also Published As

Publication number Publication date
CA2471110C (en) 2017-01-31
SI1491553T1 (sl) 2011-12-30
NO333259B1 (no) 2013-04-22
US7947287B2 (en) 2011-05-24
BR0215213A (pt) 2004-12-07
AU2002361922B2 (en) 2007-04-05
CR7361A (es) 2005-02-18
AU2002361922A1 (en) 2003-07-09
US7374767B2 (en) 2008-05-20
KR20050002811A (ko) 2005-01-10
DOP2002000548A (es) 2003-06-30
CA2471110A1 (en) 2003-07-03
MA27868A1 (fr) 2006-05-02
MXPA04005832A (es) 2004-09-13
KR100642437B1 (ko) 2006-11-06
TNSN04114A1 (en) 2006-06-01
RU2004122084A (ru) 2005-03-27
DK1491553T3 (da) 2011-12-05
IL162633A0 (is) 2005-11-20
ZA200405514B (en) 2005-03-30
IS7320A (is) 2004-06-16
UA81403C2 (en) 2008-01-10
NO20043112L (no) 2004-07-20
BRPI0215213C1 (pt) 2021-05-25
MY133530A (en) 2007-11-30
NZ534170A (en) 2006-08-31
CN1620464A (zh) 2005-05-25
HN2002000377A (es) 2003-04-10
UY27602A1 (es) 2003-04-30
US20060233742A1 (en) 2006-10-19
JP4056476B2 (ja) 2008-03-05
CN100368431C (zh) 2008-02-13
EP1491553A1 (en) 2004-12-29
ES2371239T3 (es) 2011-12-28
ATE520704T1 (de) 2011-09-15
US20090005294A1 (en) 2009-01-01
HRP20040663B1 (hr) 2013-05-31
CU23225A1 (es) 2007-08-30
JP2005525090A (ja) 2005-08-25
PE20030861A1 (es) 2003-12-02
PT1491553E (pt) 2011-11-25
EP2383282A1 (en) 2011-11-02
EP1491553B1 (en) 2011-08-17
HRP20040663A2 (en) 2005-08-31
HK1068901A1 (en) 2005-05-06
WO2003054002A1 (es) 2003-07-03
IL162633A (en) 2011-02-28
RU2290410C2 (ru) 2006-12-27
BRPI0215213B1 (pt) 2018-09-11
AR037825A1 (es) 2004-12-09

Similar Documents

Publication Publication Date Title
HK1068901A1 (en) Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
IS6965A (is) Ganglíósíð-tengd raðbrigða mótefni og notkun þeirra í sjúkdómsgreiningu og meðferð á æxlum
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
IL202332A0 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
HUP0500060A3 (en) Human coagulation factor vii polypeptides
HK1162948A1 (zh) 哈米特林 衍生物及其在治療癌症中的應用
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
HK1080840A1 (en) Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
AU2002243802A1 (en) Methods and apparatus for facilitating the provision of services
ZA200500882B (en) Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis of treatment or liver disorders and epithelial cancer
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
IS7136A (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
DK1229906T3 (da) Mesoprogestiner til behandlingen og forebyggelsen af godartede, hormonafhængige, gynækologiske lidelser
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2003258134A8 (en) Lung cancer target proteins and use thereof
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
EP1411964A4 (en) THE BLOOD GENERATING PEPTIDES AND THEIR USES
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2003268463A8 (en) Asialo-interferons and the treatment of liver cancer
DK1395331T3 (da) Anordning til behandling af svulster